<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Fenofibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:54 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Fenofibrat_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Fenofibrat_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Fenofibrat_files/filelist.xml">
<title>FENOFIBRAT</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>6</o:TotalTime>
  <o:Created>2006-08-08T14:05:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:05:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>884</o:Words>
  <o:Characters>5044</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>42</o:Lines>
  <o:Paragraphs>11</o:Paragraphs>
  <o:CharactersWithSpaces>5917</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:normal'><span
style='font-size:15.0pt'>FENOFIBRAT<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

<h2 align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tên chung qu&#7889;c t&#7871;:<i> </i></span><span
style='font-size:14.0pt;font-weight:normal'>Fenofibrate.<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><b><span
style='font-size:14.0pt'>Mã ATC: </span></b><span style='font-size:14.0pt'>C10A
B05.<b><o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><b><span
style='font-size:14.0pt'>Lo&#7841;i thu&#7889;c: </span></b><span
style='font-size:14.0pt'>Thu&#7889;c h&#7841; lipid máu (nhóm fibrat).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Nang 67 mg, 100 mg, 200 mg (vi h&#7841;t).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat, d&#7851;n ch&#7845;t c&#7911;a acid
fibric, là thu&#7889;c h&#7841; lipid máu. Thu&#7889;c &#7913;c ch&#7871; sinh
t&#7893;ng h&#7907;p cholesterol &#7903; gan, làm gi&#7843;m các thành ph&#7847;n
gây v&#7919;a x&#417; (lipoprotein t&#7927; tr&#7885;ng r&#7845;t th&#7845;p
VLDL và lipoprotein t&#7927; tr&#7885;ng th&#7845;p LDL) làm t&#259;ng s&#7843;n
xu&#7845;t lipoprotein t&#7927; tr&#7885;ng cao (HDL), và còn làm gi&#7843;m
triglycerid máu. Do &#273;ó, c&#7843;i thi&#7879;n &#273;áng k&#7875; s&#7921;
phân b&#7889; cholesterol trong huy&#7871;t t&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat &#273;&#432;&#7907;c dùng &#273;&#7875;
&#273;i&#7873;u tr&#7883; t&#259;ng lipoprotein - huy&#7871;t typ IIa, typ IIb,
typ III, typ IV và typ V cùng v&#7899;i m&#7897;t ch&#7871; &#273;&#7897;
&#259;n r&#7845;t h&#7841;n ch&#7871; v&#7873; lipid. Fenofibtrat có th&#7875;
làm gi&#7843;m 20 - 25% cholesterol toàn ph&#7847;n và 40 - 50% triglycerid
trong máu. Ði&#7873;u tr&#7883; b&#7857;ng fenofibrat c&#7847;n ph&#7843;i liên
t&#7909;c. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c</span></i><span
style='font-size:14.0pt'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat &#273;&#432;&#7907;c h&#7845;p thu ngay &#7903;
&#273;&#432;&#7901;ng tiêu hóa cùng v&#7899;i th&#7913;c &#259;n. H&#7845;p thu
thu&#7889;c b&#7883; gi&#7843;m nhi&#7873;u n&#7871;u u&#7889;ng sau khi nh&#7883;n
&#259;n qua &#273;êm. Thu&#7889;c nhanh chóng th&#7911;y phân thành acid
fenofibric có ho&#7841;t tính; ch&#7845;t này g&#7855;n nhi&#7873;u vào albumin
huy&#7871;t t&#432;&#417;ng và có th&#7875; &#273;&#7849;y các thu&#7889;c
kháng vitamin K ra kh&#7887;i v&#7883; trí g&#7855;n. N&#7891;ng &#273;&#7897;
&#273;&#7881;nh trong huy&#7871;t t&#432;&#417;ng xu&#7845;t hi&#7879;n kho&#7843;ng
5 gi&#7901; sau khi u&#7889;ng thu&#7889;c. &#7902; ng&#432;&#7901;i có ch&#7913;c
n&#259;ng th&#7853;n bình th&#432;&#7901;ng, n&#7917;a &#273;&#7901;i trong huy&#7871;t
t&#432;&#417;ng vào kho&#7843;ng 20 gi&#7901; nh&#432;ng th&#7901;i gian này
t&#259;ng lên r&#7845;t nhi&#7873;u &#7903; ng&#432;&#7901;i m&#7855;c b&#7879;nh
th&#7853;n và acid fenofibric tích l&#361;y &#273;áng k&#7875; &#7903; ng&#432;&#7901;i
b&#7879;nh suy th&#7853;n u&#7889;ng fenofibrat h&#7857;ng ngày. Acid
fenofibric &#273;ào th&#7843;i ch&#7911; y&#7871;u theo n&#432;&#7899;c ti&#7875;u
(70% trong vòng 24 gi&#7901;, 88% trong vòng 6 ngày), ch&#7911; y&#7871;u d&#432;&#7899;i
d&#7841;ng liên h&#7907;p glucuronic, ngoài ra còn có acid fenofibric d&#432;&#7899;i
d&#7841;ng kh&#7917; và ch&#7845;t liên h&#7907;p glucuronic c&#7911;a nó.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không th&#7845;y x&#7843;y ra &#273;i&#7873;u gì nghiêm
tr&#7885;ng khi ng&#7915;ng dùng fibrat, th&#7853;m chí sau khi &#273;ã &#273;i&#7873;u
tr&#7883; lâu ngày và c&#7855;t thu&#7889;c &#273;&#7897;t ng&#7897;t.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat &#273;&#432;&#7907;c s&#7917; d&#7909;ng
trong &#273;i&#7873;u tr&#7883; r&#7889;i lo&#7841;n lipoprotein huy&#7871;t
các tip IIa, IIb, III, IV và V, ph&#7889;i h&#7907;p v&#7899;i ch&#7871; &#273;&#7897;
&#259;n.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Suy th&#7853;n n&#7863;ng. R&#7889;i lo&#7841;n ch&#7913;c
n&#259;ng gan n&#7863;ng. Tr&#7867; d&#432;&#7899;i 10 tu&#7893;i.<b><o:p></o:p></b></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Nh&#7845;t thi&#7871;t ph&#7843;i th&#259;m dò ch&#7913;c
n&#259;ng gan và th&#7853;n c&#7911;a ng&#432;&#7901;i b&#7879;nh tr&#432;&#7899;c
khi b&#7855;t &#273;&#7847;u dùng fibrat.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>&#7902; ng&#432;&#7901;i b&#7879;nh u&#7889;ng thu&#7889;c
ch&#7889;ng &#273;ông máu: Khi b&#7855;t &#273;&#7847;u dùng fibrat, c&#7847;n
gi&#7843;m li&#7873;u thu&#7889;c ch&#7889;ng &#273;ông xu&#7889;ng ch&#7881;
còn m&#7897;t ph&#7847;n ba li&#7873;u c&#361; và &#273;i&#7873;u ch&#7881;nh n&#7871;u
c&#7847;n. C&#7847;n theo dõi th&#432;&#7901;ng xuyên h&#417;n l&#432;&#7907;ng
prothrombin máu. Ði&#7873;u ch&#7881;nh li&#7873;u thu&#7889;c ch&#7889;ng
&#273;ông trong quá trình dùng và sau khi ng&#7915;ng dùng fibrat 8 ngày. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Nh&#432;&#7907;c n&#259;ng giáp có th&#7875; là m&#7897;t
y&#7871;u t&#7889; làm t&#259;ng kh&#7843; n&#259;ng b&#7883; tác d&#7909;ng ph&#7909;
&#7903; c&#417;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>C&#7847;n &#273;o transaminase 3 tháng m&#7897;t l&#7847;n,
trong 12 tháng &#273;&#7847;u dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ph&#7843;i t&#7841;m ng&#7915;ng dùng thu&#7889;c n&#7871;u
th&#7845;y SGPT (ALT) &gt; 100 &#273;&#417;n v&#7883; qu&#7889;c t&#7871;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không k&#7871;t h&#7907;p fenofibrat v&#7899;i các thu&#7889;c
có tác d&#7909;ng &#273;&#7897;c v&#7899;i gan.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Bi&#7871;n ch&#7913;ng m&#7853;t d&#7877; x&#7843;y ra
&#7903; ng&#432;&#7901;i b&#7879;nh x&#417; &#7913; gan m&#7853;t ho&#7863;c có
s&#7887;i m&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>N&#7871;u sau vài tháng dùng thu&#7889;c (3 - 6 tháng)
mà th&#7845;y l&#432;&#7907;ng lipid trong máu thay &#273;&#7893;i không
&#273;áng k&#7875; thì ph&#7843;i xem xét tr&#7883; li&#7879;u khác (b&#7893;
sung ho&#7863;c khác).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không dùng viên 300 mg cho tr&#7867; em; ch&#7881;
dùng viên có hàm l&#432;&#7907;ng này cho ng&#432;&#7901;i b&#7879;nh c&#7847;n
dùng li&#7873;u 300 mg fenofibrat/ngày.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không nên dùng trong th&#7901;i k&#7923; mang thai.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không có d&#7919; li&#7879;u. Tuy nhiên, vì an toàn,
không nên dùng cho ng&#432;&#7901;i cho con bú.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tác d&#7909;ng không mong mu&#7889;n th&#432;&#7901;ng
nh&#7865; và ít g&#7863;p.<i><o:p></o:p></i></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tiêu hóa: R&#7889;i lo&#7841;n tiêu hóa, tr&#432;&#7899;ng
vùng th&#432;&#7907;ng v&#7883;, bu&#7891;n nôn, ch&#432;&#7899;ng b&#7909;ng, &#7881;a
ch&#7843;y nh&#7865;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Da: N&#7893;i ban, n&#7893;i mày &#273;ay, ban không
&#273;&#7863;c hi&#7879;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Gan: T&#259;ng transaminase huy&#7871;t thanh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>C&#417;: Ðau nh&#7913;c c&#417;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><i><span
style='font-size:14.0pt'>Hi&#7871;m g&#7863;p, ADR &lt; 1/1000<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Gan: S&#7887;i &#273;&#432;&#7901;ng m&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Sinh d&#7909;c: M&#7845;t d&#7909;c tính và li&#7879;t
d&#432;&#417;ng, gi&#7843;m tinh trùng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Máu: Gi&#7843;m b&#7841;ch c&#7847;u. <span
style='mso-tab-count:1'> </span><o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>T&#7841;m ng&#7915;ng dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Li&#7873;u l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ði&#7873;u tr&#7883; fenofibrat nh&#7845;t thi&#7871;t
ph&#7843;i ph&#7889;i h&#7907;p v&#7899;i ch&#7871; &#273;&#7897; &#259;n h&#7841;n
ch&#7871; lipid. Ph&#7843;i u&#7889;ng thu&#7889;c cùng v&#7899;i b&#7919;a
&#259;n. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Ng&#432;&#7901;i l&#7899;n: 300 mg/ngày (1 viên 300
mg, u&#7889;ng vào m&#7897;t b&#7919;a &#259;n chính ho&#7863;c u&#7889;ng 3 l&#7847;n,
m&#7895;i l&#7847;n 1 viên <br>
100 mg cùng v&#7899;i các b&#7919;a &#259;n). Li&#7873;u ban &#273;&#7847;u th&#432;&#7901;ng
là 200 mg m&#7897;t ngày (u&#7889;ng m&#7897;t l&#7847;n ho&#7863;c chia làm 2
l&#7847;n). N&#7871;u cholesterol toàn ph&#7847;n trong máu v&#7851;n còn cao h&#417;n
4 g/l thì có th&#7875; t&#259;ng li&#7873;u lên 300 mg/ngày. C&#7847;n duy trì
li&#7873;u ban &#273;&#7847;u cho &#273;&#7871;n khi cholesterol máu tr&#7903;
l&#7841;i bình th&#432;&#7901;ng; sau &#273;ó có th&#7875; gi&#7843;m nh&#7865;
li&#7873;u hàng ngày xu&#7889;ng. Ph&#7843;i ki&#7875;m tra cholesterol máu 3
tháng m&#7897;t l&#7847;n. N&#7871;u các thông s&#7889; lipid máu l&#7841;i
t&#259;ng lên thì ph&#7843;i t&#259;ng li&#7873;u lên 300 mg/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Tr&#7867; &gt; 10 tu&#7893;i: C&#7847;n nghiên c&#7913;u
k&#7929; &#273;&#7875; xác &#273;&#7883;nh c&#259;n nguyên chính xác c&#7911;a
t&#259;ng lipid máu &#7903; tr&#7867;. Có th&#7875; &#273;i&#7873;u tr&#7883;
th&#7917; k&#7871;t h&#7907;p v&#7899;i m&#7897;t ch&#7871; &#273;&#7897;
&#259;n &#273;&#432;&#7907;c ki&#7875;m soát ch&#7863;t ch&#7869; trong vòng 3
tháng. Li&#7873;u t&#7889;i &#273;a khuyên dùng là 5 mg/kg/ngày. Trong m&#7897;t
s&#7889; tr&#432;&#7901;ng h&#7907;p &#273;&#7863;c bi&#7879;t (t&#259;ng lipid
máu r&#7845;t cao kèm theo d&#7845;u hi&#7879;u lâm sàng c&#7911;a v&#7919;a x&#417;
&#273;&#7897;ng m&#7841;ch, cha m&#7865; có bi&#7875;u hi&#7879;n tim m&#7841;ch
do x&#417; v&#7919;a tr&#432;&#7899;c 40 tu&#7893;i, có &#273;ám &#273;&#7885;ng
xanthom...) thì có th&#7875; dùng li&#7873;u cao h&#417;n nh&#432;ng ph&#7843;i
do th&#7847;y thu&#7889;c chuyên khoa ch&#7881; &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>N&#7871;u n&#7891;ng &#273;&#7897; lipid trong máu
không gi&#7843;m nhi&#7873;u sau 3 &#273;&#7871;n 6 tháng &#273;i&#7873;u tr&#7883;
b&#7857;ng fenofibrat thì c&#7847;n thay &#273;&#7893;i tr&#7883; li&#7879;u
(tr&#7883; li&#7879;u b&#7893; sung ho&#7863;c tr&#7883; li&#7879;u khác).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Dùng k&#7871;t h&#7907;p các thu&#7889;c &#7913;c ch&#7871;
HMG CoA reductase (ví d&#7909;: pravastatin, simvastatin, fluvastatin) và
fibrat s&#7869; làm t&#259;ng &#273;áng k&#7875; nguy c&#417; t&#7893;n th&#432;&#417;ng
c&#417; và viêm t&#7909;y c&#7845;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>K&#7871;t h&#7907;p fibrat v&#7899;i ciclosporin làm
t&#259;ng nguy c&#417; t&#7893;n th&#432;&#417;ng c&#417;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat làm t&#259;ng tác d&#7909;ng c&#7911;a các
thu&#7889;c u&#7889;ng ch&#7889;ng &#273;ông và do &#273;ó làm t&#259;ng nguy c&#417;
xu&#7845;t huy&#7871;t do &#273;&#7849;y các thu&#7889;c này ra kh&#7887;i v&#7883;
trí g&#7855;n v&#7899;i protein huy&#7871;t t&#432;&#417;ng. C&#7847;n theo dõi
l&#432;&#7907;ng prothrombin th&#432;&#7901;ng xuyên h&#417;n và &#273;i&#7873;u
ch&#7881;nh li&#7873;u thu&#7889;c u&#7889;ng ch&#7889;ng &#273;ông trong su&#7889;t
th&#7901;i gian &#273;i&#7873;u tr&#7883; b&#7857;ng fenofibrat và sau khi ng&#7915;ng
thu&#7889;c 8 ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Không &#273;&#432;&#7907;c dùng k&#7871;t h&#7907;p
các thu&#7889;c &#273;&#7897;c v&#7899;i gan (thu&#7889;c &#7913;c ch&#7871;
MAO, perhexilin maleat...) v&#7899;i fenofi- <br>
brat.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Ð&#7897; &#7893;n &#273;&#7883;nh và b&#7843;o
qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>B&#7843;o qu&#7843;n thu&#7889;c n&#417;i khô ráo,
tránh &#7849;m.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Th&#7849;m tách máu không có tác d&#7909;ng lo&#7841;i
b&#7887; thu&#7889;c kh&#7887;i c&#417; th&#7875;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
normal'><span style='font-size:14.0pt'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Fenofibrat có trong danh m&#7909;c thu&#7889;c thi&#7871;t
y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; 4 n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Thu&#7889;c &#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'>Thành ph&#7849;m gi&#7843;m &#273;&#7897;c: Thu&#7889;c
viên có hàm l&#432;&#7907;ng t&#7889;i &#273;a 300 mg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:normal'><span
style='font-size:14.0pt'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Fenofibrat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:54 GMT -->
</html>
